Latest Press Releases

GSK
3 years ago ⋅ English ⋅ 8 min read
Newsroom
GSK to showcase scientific advances and progress in oncology at ASCO and EHA

Company will share findings from 34 abstracts at oncology annual scientific congresses American Society of Clinical Oncology and European Hematology Association spanning priority areas... Read More
GSK
3 years ago ⋅ English ⋅ 5 min read
Newsroom
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate

For media and investors only- Two-stage design will evaluate vaccine formulations targeting original D.614 virus as well as B.1.351 variant, in diverse geographies with multiple circula... Read More
GSK
3 years ago ⋅ English ⋅ 15 min read
Newsroom
GSK and Vir Biotechnology announce sotrovimab (VIR-7831) receives Emergency Use Authorization from the US FDA for treatment of mild-to-moderate COVID-19 in high-risk adults and paediatric patients

For media and investors onlyIssued: London UK and San Francisco US- Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalisation or death in high-risk adult out... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK announced as a Principal Partner of COP26 UN Climate Change Conference

For media and investors only- Builds on and contributes to company target of being carbon net zero and nature net positive by 2030- As Principal Partner, GSK will drive action on climat... Read More
GSK
3 years ago ⋅ English ⋅ 11 min read
Newsroom
EMA issues positive scientific opinion on GSK and Vir Biotechnology’s sotrovimab for the early treatment of COVID-19

For media and investors only- Opinion based on the EMA’s Committee for Human Medicinal Products (CHMP) review of available data on sotrovimab (previously VIR-7831) for the early t... Read More
GSK
3 years ago ⋅ English ⋅ 1 min read
Newsroom
GSK announces sale of stake in Innoviva Inc

Shares to be sold back to Innoviva at $12.25 per shareFor media and investors onlyIssued: 20 May 2021, London UKGlaxoSmithKline has agreed with Innoviva, Inc (“Innoviva”) -... Read More
GSK
3 years ago ⋅ English ⋅ 5 min read
Newsroom
Medicago and GSK announce positive interim Phase 2 results for adjuvanted COVID-19 vaccine candidate

For media and investors only- Similar antibody response in adults and in the elderly after two doses- Neutralizing antibody responses were ten times higher than in people recovering fro... Read More
GSK
3 years ago ⋅ English ⋅ 5 min read
Newsroom
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial

For media and investors only- Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups- High immune response after a si... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK Consumer Healthcare commits to make over a billion toothpaste tubes recyclable by 2025 as part of its ongoing sustainability journey

For media and investors onlyGSK Consumer Healthcare (GSKCH), the world-leading consumer healthcare business, announced today that it is partnering with two global packaging suppliers to... Read More
GSK
3 years ago ⋅ English ⋅ 9 min read
Newsroom
GSK and Vir Biotechnology announce the start of the EMA rolling review of VIR-7831 (sotrovimab) for the early treatment of COVID-19

For media and investors onlyIssued: London UK and San Francisco US- Rolling review will evaluate sotrovimab in adults and adolescents with COVID-19 who do not require oxygen supplementa... Read More
GSK
3 years ago ⋅ English ⋅ 7 min read
Newsroom
European Commission approves Benlysta for adult patients with active lupus nephritis

First and only biologic approved for both systemic lupus erythematosus and lupus nephritisFor media and investors onlyGlaxoSmithKline plc (GSK) today announced the European Commission h... Read More
GSK
3 years ago ⋅ English ⋅ 6 min read
Newsroom
ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV

For media and investors onlyViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareh... Read More
Nestlé
3 years ago ⋅ English ⋅ 2 min read
Newsroom
Nestlé to acquire core brands of The Bountiful Company, expands health and nutrition portfolio

Nestlé and KKR today have entered into an agreement in which Nestlé will acquire core brands of The Bountiful Company for USD 5.75 billion. The Bountiful Company is the number one pure-... Read More
GSK
3 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK delivers Q1 sales of £7.4 billion -18% AER, -15% CER Total EPS 21.5p, -32% AER, -25% CER; Adjusted EPS 22.9p -39% AER, -33% CER

For media and investors onlyQ1 performance reflects expected year-on-year impact and disruption from COVID-19On track to create New GSK and New Consumer Healthcare company in 2022Full r... Read More
Nestlé
3 years ago ⋅ English ⋅ 1 min read
Newsroom
Nestlé in discussions to acquire The Bountiful Company

Nestlé S.A. today announced that it is in discussions to acquire all or part of The Bountiful Company.Christoph Meier Tel.: +41 21 924 2200Jacquelyn Campo Tel.: +41 21 924 3855Luca Borl... Read More
GSK
3 years ago ⋅ English ⋅ 9 min read
Newsroom
European Commission approves GSK’s JEMPERLI (dostarlimab), the first anti-PD-1 therapy approved for recurrent or advanced endometrial cancer

For media and investors onlyGlaxoSmithKline (LSE/NYSE: GSK) plc today announced the European Commission has granted conditional marketing authorisation for JEMPERLI (dostarlimab), a pro... Read More
GSK
3 years ago ⋅ English ⋅ 11 min read
Newsroom
FDA grants accelerated approval for GSK’s JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancer

For media and investors only- GARNET study represents the largest dataset of anti-PD-1 monotherapy treatment of women with endometrial cancer- Study results showed an overall response r... Read More
Nestlé
3 years ago ⋅ English ⋅ 11 min read
Newsroom
Nestlé reports three-month sales for 2021

14:00 CEST Investor call audio webcast- Organic growth reached 7.7%, with real internal growth (RIG) of 6.4% and pricing of 1.2%. Growth was broad-based across most geographies, support... Read More
GSK
3 years ago ⋅ English ⋅ 9 min read
Newsroom
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19

For media and investors onlyIssued: London UK and San Francisco USGSK and Vir continue discussions with global regulators to make VIR-7831 available to patients with COVID-19.GlaxoSmith... Read More
Nestlé
3 years ago ⋅ English ⋅ 1 min read
Newsroom
Nestlé releases the results from its Annual General Meeting

Nestlé S.A. shareholders approved all of the Board of Directors’ proposals at the 154th Annual General Meeting (AGM) that took place in Vevey today. This included the election of Lindiw... Read More
GSK
3 years ago ⋅ English ⋅ 1 min read
Newsroom
GSK provides update on feladilimab, an investigational inducible T cell co-stimulatory (ICOS) agonist

GlaxoSmithKline plc today announced, following a recommendation by the Independent Data Monitoring Committee, that it has taken the decision to stop enrolling patients in the phase II I... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK announces Dr Anne Beal to join the Board as Non-Executive Director

For media and investors onlyGlaxoSmithKline plc (LSE/NYSE: GSK) today announces that Dr Anne Beal will join the Board of the Company as a Non-Executive Director with effect from 6 May 2... Read More
Nestlé
3 years ago ⋅ English ⋅ 1 min read
Newsroom
Nestlé closes the sale of Nestlé Waters North America brands

Nestlé S.A. today announced the closing of the sale of Nestlé Waters North America brands to One Rock Capital Partners in partnership with Metropoulos & Co. for USD 4.3 billion.
GSK
3 years ago ⋅ English ⋅ 7 min read
Newsroom
GSK to support manufacture of Novavax’ COVID-19 vaccine

For media and investors onlyIssued: London, UK, Gaithersburg, MD- GSK to support manufacture of up to 60 million doses of Novavax’ COVID-19 vaccine- Manufacturing to take place at... Read More
GSK
3 years ago ⋅ English ⋅ 13 min read
Newsroom
Lilly, Vir Biotechnology and GSK announce positive topline data from the phase 2 BLAZE-4 trial evaluating bamlanivimab with VIR-7831 in low-risk adults with COVID-19

For media and investors onlyIssued: London UK; San Francisco and Indianapolis US- In combination, the two monoclonal antibodies demonstrated a 70% relative reduction in persistently hig... Read More
GSK
3 years ago ⋅ English ⋅ 8 min read
Newsroom
GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for VIR-7831 for the early treatment of COVID-19

For media and investors onlyIssued: London, UK and San Francisco, USGlaxoSmithKline plc and Vir Biotechnology, Inc. today announced the submission of an application to the U.S. Food and... Read More
Nestlé
3 years ago ⋅ English ⋅ 1 min read
Newsroom
Nestlé publishes 2020 Annual Report, spotlights sustainability at the Annual General Meeting

Nestlé today published its 2020 Annual Report. The report highlights the company’s financial and non-financial performance for the year and gives an update on strategy, innovation, digi... Read More
Nestlé
3 years ago ⋅ English ⋅ 1 min read
Newsroom
Nestlé nominates Lindiwe Majele Sibanda to join its Board of Directors, provides update on Annual General Meeting

Nestlé announced today that it proposes Lindiwe Majele Sibanda for election to its Board of Directors. The elections will take place at the company’s Annual General Meeting on April 15,... Read More
Nestlé
3 years ago ⋅ English ⋅ 18 min read
Newsroom
Nestlé reports full-year results for 2020

Follow today's events live09:00 CET Press conference webcast14:00 CET Investor call audio webcast- Organic growth reached 3.6%, with real internal growth (RIG) of 3.2% and pricing of 0.... Read More
Nestlé
3 years ago ⋅ English ⋅ 1 min read
Newsroom
Nestlé continues strategic transformation of water business, agrees on sale of Nestlé Waters North America brands

Nestlé S.A. today announced that it has reached an agreement to sell its regional spring water brands, purified water business and beverage delivery service in the U.S. and Canada to On... Read More